$MLAB
MESA LABORATORIES INC /CO/ Stock $mlab

$mlab Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000110465913008785 Filed on February 08, 2013

Income Statement

Concept	2013 Q1	2012 Q4	2011 Q4
Revenue	$12.81M	$11.36M	$9.650M
YoY Change	16.77%	17.73%	26.14%
Cost Of Revenue	$4.600M	$4.414M	$3.765M
YoY Change	2.22%	17.24%	17.29%
Gross Profit	$8.211M	$6.947M	$5.885M
YoY Change	27.03%	18.05%	32.55%
Gross Profit Margin	64.1%	61.15%	60.98%
Selling, General & Admin	$3.670M	$3.982M	$2.381M
YoY Change	47.98%	67.24%	36.06%
% of Gross Profit	44.7%	57.32%	40.46%
Research & Development	$610.0K	$501.0K	$342.0K
YoY Change	103.33%	46.49%	-12.98%
% of Gross Profit	7.43%	7.21%	5.81%
Depreciation & Amortization	$840.0K	$910.0K	$540.0K
YoY Change	44.83%	68.52%	14.89%
% of Gross Profit	10.23%	13.1%	9.18%
Operating Expenses	$4.280M	$4.483M	$2.723M
YoY Change	53.96%	64.63%	592.88%
Operating Profit	$3.931M	$2.464M	$3.162M
YoY Change	6.7%	-22.07%	-21.87%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$20.00K	-$40.00K	-$30.00K
YoY Change	0.0%	33.33%	-9.09%
Pretax Income	$3.910M	$2.426M	$3.131M
YoY Change	17.77%	-22.52%	59.01%
Income Tax	$1.360M	$883.0K	$1.144M
% Of Pretax Income	34.78%	36.4%	36.54%
Net Earnings	$2.560M	$1.540M	$1.990M
YoY Change	16.36%	-22.61%	57.94%
Net Earnings / Revenue	19.98%	13.56%	20.62%
Basic Earnings Per Share	$0.76	$0.46	$0.60
Diluted Earnings Per Share	$0.71	$0.44	$0.57
COMMON SHARES
Basic Shares Outstanding	3.380M shares	3.360M shares	3.286M shares
Diluted Shares Outstanding		3.542M shares	3.498M shares

Balance Sheet

Concept	2013 Q1	2012 Q4	2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.000M	$2.700M	$5.700M
YoY Change	-44.44%	-52.63%	171.43%
Cash & Equivalents	$4.006M	$2.722M	$5.691M
Short-Term Investments
Other Short-Term Assets	$1.400M	$1.000M	$800.0K
YoY Change	40.0%	25.0%	33.33%
Inventory	$5.576M	$5.281M	$4.900M
Prepaid Expenses
Receivables	$8.474M	$7.595M	$6.100M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$19.46M	$16.56M	$17.50M
YoY Change	1.53%	-5.38%	23.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.406M	$7.328M	$7.300M
YoY Change	1.93%	0.38%	-1.35%
Goodwill	$23.64M	$23.64M
YoY Change	63.6%
Intangibles	$15.42M	$16.09M
YoY Change	57.02%
Long-Term Investments
YoY Change
Other Assets		$0.00
YoY Change
Total Long-Term Assets	$46.46M	$47.06M	$32.72M
YoY Change	47.34%	43.81%	-2.03%
TOTAL ASSETS
Total Short-Term Assets	$19.46M	$16.56M	$17.50M
Total Long-Term Assets	$46.46M	$47.06M	$32.72M
Total Assets	$65.92M	$63.62M	$50.22M
YoY Change	30.03%	26.67%	5.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.010M	$883.0K	$600.0K
YoY Change	76.27%	47.17%	-45.45%
Accrued Expenses	$422.0K	$488.0K	$1.700M
YoY Change	-16.27%	-71.29%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due			$1.000M
YoY Change			25.0%
Total Short-Term Liabilities	$4.662M	$3.859M	$4.630M
YoY Change	9.39%	-16.65%	-45.53%
LONG-TERM LIABILITIES
Long-Term Debt	$4.000M	$5.000M	$800.0K
YoY Change		525.0%	-55.56%
Other Long-Term Liabilities	$2.100M	$2.100M
YoY Change
Total Long-Term Liabilities	$4.000M	$5.000M	$800.0K
YoY Change		525.0%	-55.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.662M	$3.859M	$4.630M
Total Long-Term Liabilities	$4.000M	$5.000M	$800.0K
Total Liabilities	$13.17M	$13.52M	$8.516M
YoY Change	94.16%	58.74%	-35.48%
SHAREHOLDERS EQUITY
Retained Earnings	$42.18M	$42.71M
YoY Change	18.0%
Common Stock	$10.72M	$7.613M
YoY Change	25.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$52.75M	$50.10M	$41.71M
YoY Change
Total Liabilities & Shareholders Equity	$65.92M	$63.62M	$50.20M
YoY Change	30.03%	26.73%	5.46%

Cashflow Statement

Concept	2013 Q1	2012 Q4	2011 Q4
OPERATING ACTIVITIES
Net Income	$2.560M	$1.540M	$1.990M
YoY Change	16.36%	-22.61%	57.94%
Depreciation, Depletion And Amortization	$840.0K	$910.0K	$540.0K
YoY Change	44.83%	68.52%	14.89%
Cash From Operating Activities	$2.950M	$3.520M	$4.300M
YoY Change	-17.6%	-18.14%	45.27%
INVESTING ACTIVITIES
Capital Expenditures	-$250.0K	-$290.0K	-$210.0K
YoY Change	92.31%	38.1%	75.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$710.0K
YoY Change	-100.0%	-100.0%	-88.6%
Cash From Investing Activities	-$250.0K	-$290.0K	-$920.0K
YoY Change	56.25%	-68.48%	-85.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.420M	-3.290M	-2.650M
YoY Change	-25.65%	24.15%	-235.9%
NET CHANGE
Cash From Operating Activities	2.950M	3.520M	4.300M
Cash From Investing Activities	-250.0K	-290.0K	-920.0K
Cash From Financing Activities	-1.420M	-3.290M	-2.650M
Net Change In Cash	1.280M	-60.00K	730.0K
YoY Change	-15.23%	-108.22%	-150.69%
FREE CASH FLOW
Cash From Operating Activities	$2.950M	$3.520M	$4.300M
Capital Expenditures	-$250.0K	-$290.0K	-$210.0K
Free Cash Flow	$3.200M	$3.810M	$4.510M
YoY Change	-13.75%	-15.52%	46.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.76
CY2012Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	573000	USD
CY2012Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2134000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7191000	USD
CY2012Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6486000	USD
CY2012Q1	us-gaap	Inventory Net InventoryNet	4438000	USD
CY2012Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1046000	USD
CY2012Q1	us-gaap	Assets Current AssetsCurrent	19161000	USD
CY2012Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7266000	USD
CY2012Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9819000	USD
CY2012Q1	us-gaap	Goodwill Goodwill	14450000	USD
CY2012Q1	us-gaap	Assets Assets	50696000	USD
CY2012Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	504000	USD
CY2012Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1051000	USD
CY2012Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4262000	USD
CY2012Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2519000	USD
CY2012Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	2140000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5000000	USD
CY2012Q1	us-gaap	Liabilities Liabilities	6781000	USD
CY2012Q1	mlab	Employee Loans To Purchase Common Stock EmployeeLoansToPurchaseCommonStock	396000	USD
CY2012Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	37612000	USD
CY2012Q1	us-gaap	Stockholders Equity StockholdersEquity	43915000	USD
CY2012Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50696000	USD
CY2012Q1	us-gaap	Common Stock Value CommonStockValue	6699000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	16558000	USD
CY2012Q4	us-gaap	Assets Assets	63617000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3859000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5891000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-119000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-582000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	8909000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	712000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	656000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1257000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	11000000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4750000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	13518000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	50099000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63617000	USD
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3370819	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3370819	shares
CY2012Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3321965	shares
CY2012Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3321965	shares
CY2012Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2012Q4	us-gaap	Gross Profit GrossProfit	6947000	USD
CY2012Q4	us-gaap	Operating Expenses OperatingExpenses	4483000	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	2464000	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2426000	USD
CY2012Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1543000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1636000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	349000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	8451000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2722000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-914000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-857000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-134000	USD
CY2011Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	9650000	USD
CY2011Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3765000	USD
CY2011Q4	us-gaap	Gross Profit GrossProfit	5885000	USD
CY2011Q4	us-gaap	Selling Expense SellingExpense	949000	USD
CY2011Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1432000	USD
CY2011Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	342000	USD
CY2011Q4	us-gaap	Operating Expenses OperatingExpenses	2723000	USD
CY2011Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	3162000	USD
CY2011Q4	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	31000	USD
CY2011Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3131000	USD
CY2011Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1144000	USD
CY2011Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1987000	USD
CY2011Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2011Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2011Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3286000	shares
CY2011Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3498000	shares
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	28648000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	11601000	USD
	us-gaap	Gross Profit GrossProfit	17047000	USD
	us-gaap	Selling Expense SellingExpense	2926000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3924000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1056000	USD
	us-gaap	Operating Expenses OperatingExpenses	7906000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	9141000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	130000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9011000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3291000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5720000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.74
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.66
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3280000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3454000	shares
	us-gaap	Operating Expenses OperatingExpenses	11478000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	9173000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9064000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1216000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	57000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	60000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	519000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-5507000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	2145000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	3280000	USD
	us-gaap	Interest Paid InterestPaid	134000	USD
	mlab	Noncash Portion Employee Loans To Purchase Common Stock NoncashPortionEmployeeLoansToPurchaseCommonStock	235000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-4469000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4396000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-17316000	USD
	dei	Entity Registrant Name EntityRegistrantName	MESA LABORATORIES INC /CO
	dei	Entity Central Index Key EntityCentralIndexKey	0000724004
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2012-12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2013Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3379518	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	mlab	Number Of Physical Locations In Which Entity Is Organized NumberOfPhysicalLocationsInWhichEntityIsOrganized	4	item
CY2012Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3890000	USD
CY2012Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	3242000	USD
CY2012Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	446000	USD
CY2012Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	331000	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1360000	USD
CY2012Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1090000	USD
CY2012Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	415000	USD
CY2012Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	225000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	5281000	USD
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	5000000	USD
CY2012Q2	us-gaap	Line Of Credit Facility Increase Additional Borrowings LineOfCreditFacilityIncreaseAdditionalBorrowings	11000000	USD
CY2013Q1	us-gaap	Line Of Credit Facility Decrease Repayments LineOfCreditFacilityDecreaseRepayments	1000000	USD
CY2012Q4	us-gaap	Line Of Credit Facility Decrease Repayments LineOfCreditFacilityDecreaseRepayments	3000000	USD
	us-gaap	Line Of Credit Facility Decrease Repayments LineOfCreditFacilityDecreaseRepayments	6000000	USD
CY2012Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5000000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	314000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	897000	USD
CY2012Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	459000	USD
CY2012Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	163000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	583000	USD
CY2012Q4	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	296000	USD
	mlab	Share Based Compensation Effect On Earning Per Share Basic ShareBasedCompensationEffectOnEarningPerShareBasic	0.17
CY2012Q4	mlab	Share Based Compensation Effect On Earning Per Share Basic ShareBasedCompensationEffectOnEarningPerShareBasic	0.09
	mlab	Share Based Compensation Effect On Earning Per Share Diluted ShareBasedCompensationEffectOnEarningPerShareDiluted	0.17
CY2012Q4	mlab	Share Based Compensation Effect On Earning Per Share Diluted ShareBasedCompensationEffectOnEarningPerShareDiluted	0.08
CY2012Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3360000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3349000	shares
CY2012Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	182000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	178000	shares
CY2012Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3542000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3527000	shares
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
CY2012Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	81000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	81000	shares
CY2012Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	11361000	USD
CY2012Q4	us-gaap	Selling Expense SellingExpense	1223000	USD
CY2012Q4	mlab	Gross Profit After Deducting Selling Expense GrossProfitAfterDeductingSellingExpense	5724000	USD
CY2011Q4	mlab	Gross Profit After Deducting Selling Expense GrossProfitAfterDeductingSellingExpense	4936000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	33627000	USD
	us-gaap	Selling Expense SellingExpense	3297000	USD
	mlab	Gross Profit After Deducting Selling Expense GrossProfitAfterDeductingSellingExpense	17354000	USD
	mlab	Gross Profit After Deducting Selling Expense GrossProfitAfterDeductingSellingExpense	14121000	USD
CY2012Q4	mlab	Threshold For Disclosure Percentage ThresholdForDisclosurePercentage	0.10	pure
CY2011Q4	mlab	Threshold For Disclosure Percentage ThresholdForDisclosurePercentage	0.10	pure
	mlab	Threshold For Disclosure Percentage ThresholdForDisclosurePercentage	0.10	pure
	mlab	Threshold For Disclosure Percentage ThresholdForDisclosurePercentage	0.10	pure
	us-gaap	Notes Reduction NotesReduction	347000	USD
CY2011Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	212000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	174000	shares
CY2011Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	157000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	349000	USD
CY2011Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	57000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	127000	USD
CY2011Q4	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	100000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	222000	USD
CY2011Q4	mlab	Share Based Compensation Effect On Earning Per Share Basic ShareBasedCompensationEffectOnEarningPerShareBasic	0.03
	mlab	Share Based Compensation Effect On Earning Per Share Basic ShareBasedCompensationEffectOnEarningPerShareBasic	0.07
CY2011Q4	mlab	Share Based Compensation Effect On Earning Per Share Diluted ShareBasedCompensationEffectOnEarningPerShareDiluted	0.03
	mlab	Share Based Compensation Effect On Earning Per Share Diluted ShareBasedCompensationEffectOnEarningPerShareDiluted	0.06
CY2012Q4	us-gaap	Entity Wide Disclosure On Geographic Areas Revenue From External Customers Attributed To Entitys Country Of Domicile EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile	7013000	USD
CY2011Q4	us-gaap	Entity Wide Disclosure On Geographic Areas Revenue From External Customers Attributed To Entitys Country Of Domicile EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile	5684000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5691000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3546000	USD
CY2012Q4	mlab	Common Stock Shares Authorized Prior To Amendment CommonStockSharesAuthorizedPriorToAmendment	8000000	shares
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7595000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	960000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7328000	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16091000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	23640000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	883000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2219000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	488000	USD
CY2012Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	269000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2519000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	7613000	USD
CY2012Q4	mlab	Employee Loans To Purchase Common Stock EmployeeLoansToPurchaseCommonStock	226000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	42712000	USD
CY2012Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4414000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	12976000	USD
CY2012Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2759000	USD
CY2012Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	501000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6782000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1399000	USD
CY2012Q4	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	38000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	109000	USD
CY2012Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	883000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3173000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2585000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	897000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	631000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-67000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-114000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	310000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-782000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	16660000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	6000000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1341000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	794000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	4125000	USD
	us-gaap	Interest Paid InterestPaid	120000	USD
	mlab	Noncash Portion Employee Loans To Purchase Common Stock NoncashPortionEmployeeLoansToPurchaseCommonStock	177000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	545000	USD
	us-gaap	Notes Reduction NotesReduction	301000	USD
	us-gaap	Entity Wide Disclosure On Geographic Areas Revenue From External Customers Attributed To Entitys Country Of Domicile EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile	20504000	USD
CY2012Q4	mlab	Provision For State Sales Taxes ProvisionForStateSalesTaxes	100000	USD
CY2011Q4	mlab	Provision For State Sales Taxes ProvisionForStateSalesTaxes	250000	USD
	us-gaap	Entity Wide Disclosure On Geographic Areas Revenue From External Customers Attributed To Entitys Country Of Domicile EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile	17497000	USD
CY2012Q4	us-gaap	Entity Wide Disclosure On Geographic Areas Revenue From External Customers Attributed To Foreign Countries EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries	4348000	USD
CY2011Q4	us-gaap	Entity Wide Disclosure On Geographic Areas Revenue From External Customers Attributed To Foreign Countries EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries	3966000	USD
	us-gaap	Entity Wide Disclosure On Geographic Areas Revenue From External Customers Attributed To Foreign Countries EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries	13123000	USD
	us-gaap	Entity Wide Disclosure On Geographic Areas Revenue From External Customers Attributed To Foreign Countries EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries	11151000	USD

Files In Submission

Name	View Source	Status
0001104659-13-008785-index-headers.html	Edgar Link	pending
0001104659-13-008785-index.html	Edgar Link	pending
0001104659-13-008785.txt	Edgar Link	pending
0001104659-13-008785-xbrl.zip	Edgar Link	pending
a12-30156_110q.htm	Edgar Link	pending
a12-30156_1ex31d1.htm	Edgar Link	pending
a12-30156_1ex31d2.htm	Edgar Link	pending
a12-30156_1ex32d1.htm	Edgar Link	pending
a12-30156_1ex32d2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
mlab-20121231.xml	Edgar Link	completed
mlab-20121231.xsd	Edgar Link	pending
mlab-20121231_cal.xml	Edgar Link	unprocessable
mlab-20121231_def.xml	Edgar Link	unprocessable
mlab-20121231_lab.xml	Edgar Link	unprocessable
mlab-20121231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLAB
MESA LABORATORIES INC /CO/ Stock $mlab

2013 Q1 Form 10-Q Financial Statement

#000110465913008785 Filed on February 08, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLAB MESA LABORATORIES INC /CO/ Stock $mlab

2013 Q1 Form 10-Q Financial Statement

#000110465913008785 Filed on February 08, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLAB
MESA LABORATORIES INC /CO/ Stock $mlab